Toolkit/biosensors
biosensors
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Biosensors have shown potential for success in diagnostic testing due to their ease of use, inexpensive materials, rapid results, and portable nature. Biosensors can be combined with nanomaterials to produce sensitive and easily interpretable results.
Usefulness & Problems
Why this is useful
Biosensors are listed as emerging technologies included in the review's coverage of efflux detection methods. They are grouped with novel technologies that offer improved precision over classical methods.; efflux detection; molecular detection; Biosensors are presented as rapid diagnostic tools for detecting bacterial resistance, including carbapenem resistance-related targets. The review highlights them as emerging alternatives to slower conventional AMR diagnostics.; rapid diagnostic testing for bacterial resistance; detection of antimicrobial resistance; portable diagnostic assays
Source:
Biosensors are listed as emerging technologies included in the review's coverage of efflux detection methods. They are grouped with novel technologies that offer improved precision over classical methods.
Source:
efflux detection
Source:
molecular detection
Source:
Biosensors are presented as rapid diagnostic tools for detecting bacterial resistance, including carbapenem resistance-related targets. The review highlights them as emerging alternatives to slower conventional AMR diagnostics.
Source:
rapid diagnostic testing for bacterial resistance
Source:
detection of antimicrobial resistance
Source:
portable diagnostic assays
Problem solved
They address limitations of older efflux detection approaches by supporting more precise detection.; providing newer detection technologies with improved precision relative to classical methods; They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.; need for inexpensive and rapid AMR detection assays
Source:
They address limitations of older efflux detection approaches by supporting more precise detection.
Source:
providing newer detection technologies with improved precision relative to classical methods
Source:
They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.
Source:
need for inexpensive and rapid AMR detection assays
Problem links
The item summary explicitly highlights ease of use, inexpensive materials, rapid results, and portability, which are core needs for diagnostics in low-resource settings. Biosensor formats could plausibly support simpler frontline detection than centralized lab methods.
We Can’t Yet Replicate Animal Olfaction Synthetically as a Sensing and Classification Modality
Gap mapView gapBiosensors are generally relevant to the synthetic sensing part of the gap because they provide practical chemical detection formats with rapid and portable readouts. They could support early prototyping of odor-responsive devices, though the supplied evidence is generic rather than olfaction-specific.
need for inexpensive and rapid AMR detection assays
LiteratureThey address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.
Source:
They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.
providing newer detection technologies with improved precision relative to classical methods
LiteratureThey address limitations of older efflux detection approaches by supporting more precise detection.
Source:
They address limitations of older efflux detection approaches by supporting more precise detection.
Published Workflows
Objective: Use biosensors to improve microbial metabolic engineering and substrate-to-product bioconversion for lignocellulosic biomass conversion.
Why it works: The abstract states that biosensors hold significant potential to advance microbial metabolic engineering and enhance substrate-to-product bioconversion, implying that integrating sensing with pathway engineering can help address optimization bottlenecks.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Target processes
diagnosticeditingImplementation Constraints
The abstract indicates that biosensors use inexpensive materials and may be combined with nanomaterials. Specific transducers, probes, or sample-preparation requirements are not given in the abstract.; may require integration with nanomaterials for improved sensitivity and interpretability
The abstract does not show that biosensors replace all gold-standard diagnostics or provide comprehensive genomic characterization. It also does not specify performance limits across organisms or sample types.; the abstract does not specify which biosensor formats or targets are most validated
Validation
Supporting Sources
Ranked Claims
Classical efflux detection methods such as MIC shifts with inhibitors and fluorometric assays have technical limitations, whereas novel technologies offer improved precision.
Classical methods for detecting efflux (e.g. minimum inhibitory concentration (MIC) shifts with inhibitors, fluorometric assays) have technical limitations, while novel technologies offer improved precision.
Biosensors have potential for diagnostic testing because they are easy to use, use inexpensive materials, provide rapid results, and are portable.
Combining biosensors with nanomaterials can produce sensitive and easily interpretable diagnostic results.
Current methods for detecting antimicrobial resistance genes are expensive and time-consuming.
Polymerase chain reactions and whole-genome sequencing are considered gold-standard diagnostics for antimicrobial resistance detection.
There is a need for inexpensive, rapid diagnostic assays for effective antimicrobial resistance detection and management.
Approval Evidence
Biosensors have shown potential for success in diagnostic testing due to their ease of use, inexpensive materials, rapid results, and portable nature. Biosensors can be combined with nanomaterials to produce sensitive and easily interpretable results.
Source:
The review integrates data from in vitro, in silico, and clinical studies, including both classical detection strategies and emerging technologies such as clustered regularly interspaced short palindromic repeats (CRISPR)-based modulation, biosensors, and microfluidics.
Source:
Classical efflux detection methods such as MIC shifts with inhibitors and fluorometric assays have technical limitations, whereas novel technologies offer improved precision.
Classical methods for detecting efflux (e.g. minimum inhibitory concentration (MIC) shifts with inhibitors, fluorometric assays) have technical limitations, while novel technologies offer improved precision.
Source:
Biosensors have potential for diagnostic testing because they are easy to use, use inexpensive materials, provide rapid results, and are portable.
Source:
Combining biosensors with nanomaterials can produce sensitive and easily interpretable diagnostic results.
Source:
There is a need for inexpensive, rapid diagnostic assays for effective antimicrobial resistance detection and management.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Source:
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Source-backed strengths
novel technologies offer improved precision; ease of use; inexpensive materials; rapid results; portable nature; can yield sensitive and easily interpretable results when combined with nanomaterials
Source:
novel technologies offer improved precision
Source:
ease of use
Source:
inexpensive materials
Source:
rapid results
Source:
portable nature
Source:
can yield sensitive and easily interpretable results when combined with nanomaterials
Compared with biosensors for active Rho detection
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Shared frame: source-stated alternative in extracted literature
Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.
Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.
Source:
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Compared with fluorescent protein based reporters and biosensors
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Shared frame: source-stated alternative in extracted literature
Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.
Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.
Source:
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Compared with genetically engineered biosensors
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Shared frame: source-stated alternative in extracted literature
Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.
Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.
Source:
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Compared with polymerase chain reactions
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Shared frame: source-stated alternative in extracted literature
Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.
Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.
Source:
The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.
Ranked Citations
- 1.
- 2.